Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
NUS research team develops portable COVID-19 diagnostic system for rapid on-site testing
And another thing…on false positives
Rhinovirus rampant or testing triumphant?
Inovio adds two to the leadership team; Adrian Woolfson is out at Sangamo
Coronavirus pharma news roundup – 26/06/20
USask researchers to develop saliva-based COVID-19 home testing kit
Early childhood vaccinations might protect children from COVID-19
Researchers develop a ‘quick and easy’ COVID-19 test
Trial starts with Imperial College London coronavirus vaccine
Researchers design COVID-19 knowledge base and risk assessment tool powered by AI
A dirty job: Tracking coronavirus using human waste
Sanofi Adds COVID-19, Flu Candidates to up to $2.3B+ mRNA Vaccine Partnership with Translate Bio
GSK begins COVID-19 vaccine trial with Clover
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
The right way to breathe during the coronavirus pandemic
Fighting the COVID-19 pandemic through testing
UK’s Imperial College begins trial of coronavirus vaccine
Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
COVID-19 vaccine to be tested in UIC clinical trial
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Houston "On The Precipice Of Disaster" As Officials Weigh Reimposing Stay At Home Order Amid Spike In Cases: Live Updates
To help West Virginia reopen safely, WVU researchers develop new COVID-19 tests
Lilly announces CNS tie-up with UK biotech Evox Therapeutics
Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit
iBio – IBIO-201
Sorrento Therapeutics and Mount Sinai Health System
Moderna's (MRNA) Stock Will Surge 80% From Current Levels, Says Analyst
Codiak BioSciences and the Ragon Institute of MGH, MIT, and Harvard
Scientists aim gene-targeting breakthrough against COVID-19